HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: CJN.00010109v1 4/5/957    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Siva, B. Articles by Johnson, D. W. Search for Related Content PubMed PubMed Citation Articles by Siva, B. Articles by Johnson, D. W.

Pseudomonas Peritonitis in Australia: Predictors, Treatment, and Outcomes in 191 Cases

Brian Siva^*,, Carmel M. Hawley^*,, Stephen P. McDonald^*,, Fiona G. Brown^*,, Johan B. Rosman^*,||, Kathryn J. Wiggins^*,¶, Kym M. Bannister^*,**, and David W. Johnson^*,

^* Australia and New Zealand Dialysis and Transplant Registry, Department of Nephrology and Transplantation Services, University of Adelaide at the Queen Elizabeth Hospital, and ^** Department of Nephrology, Royal Adelaide Hospital, Adelaide, South Australia, Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, and Department of Nephrology, Monash Medical Center, Clayton, and ^¶ University of Melbourne Department of Medicine, St. Vincent's Hospital, Fitzroy, Victoria, Australia; and ^|| Renal Department, Middlemore Hospital, Otahuhu, Auckland, New Zealand

Correspondence: Prof. David W. Johnson, Department of Nephrology, Level 2, ARTS Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Qld 4102, Australia. Phone: +61-7-3240-5080; Fax: +61-7-3240-5480; E-mail: david_johnson{at}health.qld.gov.au

Background and objectives: Pseudomonas peritonitis is a serious complication of peritoneal dialysis. To date, there as been no comprehensive, multicenter study of this condition.

Design, setting, participants, & measurements: The predictors, treatment, and clinical outcomes of Pseudomonas peritonitis were examined by binary logistic regression and multilevel, multivariate Poisson regression in all Australian PD patients in 66 centers between 2003 and 2006.

Results: A total of 191 episodes of Pseudomonas peritonitis (5.3% of all peritonitis episodes) occurred in 171 individuals. Its occurrence was independently predicted by Maori/Pacific Islander race, Aboriginal/Torres Strait Islander race, and absence of baseline peritoneal equilibration test data. Compared with other organisms, Pseudomonas peritonitis was associated with greater frequencies of hospitalization (96 versus 79%; P = 0.006), catheter removal (44 versus 20%; P < 0.001), and permanent hemodialysis transfer (35 versus 17%; P < 0.001) but comparable death rates (3 versus 2%; P = 0.4). Initial empiric antibiotic choice did not influence outcomes, but subsequent use of dual anti-pseudomonal therapy was associated with a lower risk for permanent hemodialysis transfer (10 versus 38%, respectively; P = 0.03). Catheter removal was associated with a lower risk for death than treatment with antibiotics alone (0 versus 6%; P < 0.05).

Conclusions: Pseudomonas peritonitis is associated with high rates of catheter removal and permanent hemodialysis transfer. Prompt catheter removal and use of two anti-pseudomonal antibiotics are associated with better outcomes.